We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Adjunctive Stent System Treats Brain Aneurysms

By HospiMedica International staff writers
Posted on 04 Jun 2019
Print article
Image: A novel stent system helps treat intracranial aneurysms (Photo courtesy of Stryker).
Image: A novel stent system helps treat intracranial aneurysms (Photo courtesy of Stryker).
A novel aneurysm adjunctive stent system helps surgeons treat wide-neck, intracranial aneurysms in conjunction with embolic detachable coils.

The Stryker Corporation (Kalamazoo, MI, USA) Neuroform Atlas Stent System is a self-expanding, open cell, nitinol stent designed to support embolic coil masses during the treatment of wide-neck intracranial, saccular aneurysms arising from a parent vessel with a diameter of greater than (or equal to) two mm, and less than or equal to 4.5 mm. The Stent has a tubular mesh design, with 4, 6, or 8 distinct sections laid out in a zig-zag pattern, depending on stent length, which are joined by two interconnecting struts, with eight radiopaque marker bands (four per end) secured to tabs on the stent.

The stent is deployed onto healthy vascular tissue in the anterior circulation of the neurovasculature; once in place, the embolic coil is delivered through the struts, which is then used to retain the embolic coils within the aneurysm. It is provided pre-loaded on a delivery wire, protected by a transfer sheath, and is available with an accessory pouch containing an optional stabilizer that can be attached to the proximal end of the stent delivery wire to facilitate handling and stabilization. The stent is available in five diameters (2.5-4.5mm) and three lengths (10mm, 15mm, and 20mm).

“Enhanced stent conformability, a low-profile delivery system, and high deployment accuracy even in distal anatomy puts Neuroform Atlas in a category of its own,” said Brian Jankowitz, MD, director of the NeuroEndovascular Fellowship program at the University of Pittsburgh Medical Center (UPMC; PA, USA). “This product is changing my clinical practice by allowing more patients with difficult aneurysms an option at endovascular treatment while improving the quality and safety of treatment.”

“Patients around the world are now benefiting from significant advancements in intracranial stents designed specifically for the treatment of wide neck aneurysms. This product is an excellent fit with our mission to make healthcare better,” said Mark Paul, president of Stryker's neurovascular division. “Meaningful clinical data enables our market leading products to better serve patients suffering from debilitating cerebrovascular disease.”

Wide-neck aneurysms are defined as having a neck greater or equal to four mm or a dome-to-neck ratio of less than two. They are often untreatable by surgical clipping, as many wide- neck aneurysms are in vessels deep within the brain that are not amendable to being treated by open brain surgery. Coiling wide neck aneurysms, on the other hand, could lead to coil protrusion and/or embolization, as it is difficult to achieve and maintain sufficiently dense coil packing of the aneurysm to permanently exclude blood flow.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Soft-Tissues Biopsy Needle
MR-CLEAR

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more